A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/1999
12/02/1999	WO1999061065A1 Cd40 binding molecules and ctl peptides for treating tumors
12/02/1999	WO1999061064A1 Mammalian genes encoding 3'-5' exonuclease
12/02/1999	WO1999061057A2 Molecules targeting cd40 and tumor cells
12/02/1999	WO1999061056A2 Methods and products for inducing mucosal immunity
12/02/1999	WO1999061052A2 Oral immunization with papillomavirus virus-like particles
12/02/1999	WO1999061032A1 Process for producing composite preparation containing nucleic acid
12/02/1999	WO1999061030A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZOÏC ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-λB
12/02/1999	WO1999060984A2 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/02/1999	WO1999051268A9 Immunomodulatory compositions of mmtv antigens and methods of using same
12/02/1999	WO1999050413A3 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
12/02/1999	WO1999049871A8 Method of inhibiting membrane-type matrix metalloproteinase
12/02/1999	WO1999048518A3 Medicament for preventing or treating papilloma virus-specific tumors
12/02/1999	WO1999043286A3 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/02/1999	WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999	CA2333392A1 Quinazolines for treating brain tumor
12/02/1999	CA2333270A1 1.alpha.-hydroxy-25-ene-vitamin d, analogs and uses thereof
12/02/1999	CA2333159A1 Method
12/02/1999	CA2333006A1 Calmodulin related protein
12/02/1999	CA2332863A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor nf-.kappa.b
12/02/1999	CA2332806A1 Bioreductive cytotoxic agents
12/02/1999	CA2332786A1 Identification of broadly reactive dr restricted epitopes
12/02/1999	CA2332772A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999	CA2332146A1 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999	CA2329506A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999	CA2329274A1 Interleukin-21
12/02/1999	CA2329156A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene
12/02/1999	CA2329136A1 Oral immunization with papillomavirus virus-like particles
12/02/1999	CA2329072A1 Human transmembrane proteins
12/02/1999	CA2329053A1 Human socs proteins
12/02/1999	CA2328905A1 Prostate growth-associated membrane proteins
12/02/1999	CA2328894A1 Methods and products for inducing mucosal immunity
12/02/1999	CA2328892A1 Tumor suppressor
12/02/1999	CA2327541A1 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
12/01/1999	EP0960941A1 Gene Therapy for cell proliferative diseases
12/01/1999	EP0960882A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/01/1999	EP0960334A1 Vegf-b/receptor complex and uses thereof
12/01/1999	EP0960208A1 Glutathione s-transferase (gst) genes in cancer
12/01/1999	EP0960204A1 Method and reagents for genetic immunization
12/01/1999	EP0960197A1 GENES FROM 20q13 AMPLICON AND THEIR USES
12/01/1999	EP0960192A1 Synthetic polynucleotides
12/01/1999	EP0960127A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
12/01/1999	EP0960123A1 Sprouty protein and coding sequence
12/01/1999	EP0960120A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
12/01/1999	EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999	EP0960115A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
12/01/1999	EP0960108A1 Matrix metalloproteinase inhibitors
12/01/1999	EP0960107A1 6-thio-substituted paclitaxels
12/01/1999	EP0960103A1 Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors)
12/01/1999	EP0960098A1 Arylsulfonyl hydroxamic acid derivatives
12/01/1999	EP0959884A1 Phosphatase inhibitors and methods of use thereof
12/01/1999	EP0959883A1 Inhibitors of farnesyl-protein transferase
12/01/1999	EP0959881A1 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom
12/01/1999	EP0959781A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins
12/01/1999	EP0800504B1 Tricyclic retinoids, methods for their production and use
12/01/1999	EP0642503B1 10-desacetoxytaxol derivatives
12/01/1999	CN1237177A Fused bicyclic pyrimidine derivatives
12/01/1999	CN1237176A Tricyclic compounds useful as FPT inhibitors
12/01/1999	CN1237171A Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
12/01/1999	CN1237170A Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
12/01/1999	CN1237169A Tricyclic compounds useful for inhibition of G-protein function and treatment of proliferative diseases
12/01/1999	CN1237168A Bicyclic aryl carboxamides and their therapeutic use
12/01/1999	CN1237165A Tricyclic inhibitors of farnesyl protein transferase
12/01/1999	CN1237164A Compounds useful for inhibition of farnesyl protein transferase
12/01/1999	CN1237162A Indene inhibitors of COX-2
12/01/1999	CN1046934C Acylfulvene analogues as antitumor agents
12/01/1999	CN1046851C Process for preparing solid oral forms containing isocyclo-phosphoamide as active substance
11/1999
11/30/1999	USRE36419 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
11/30/1999	US5994576 Have utility as antileukemia and antitumor agents.
11/30/1999	US5994569 Useful in the treatment or prevention of vitamin d dependent disorders and of il-12-dependent autoimmune diseases
11/30/1999	US5994547 Process for preparing benzo[b]thiophenes
11/30/1999	US5994535 Water soluble texaphyrin metal complex preparation
11/30/1999	US5994523 A nucleic acid molecule encoding a peptide comprising a sequence consisting of 8 contiguous amino acids of th mart-1(melanoma antigen recognized by t-cell-1) a preferential amino acid sequence which is capable of reacting tumor
11/30/1999	US5994513 Oncoprotein protein kinase
11/30/1999	US5994500 Antagonists of intestinotrophic GLP-2 peptides
11/30/1999	US5994409 Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
11/30/1999	US5994388 Cytochalasin and isoindolinone derivatives as inhibitors of angiogenesis
11/30/1999	US5994379 Analgesics; antiinflammatory agent; antipyretics
11/30/1999	US5994371 Carbamate derivatives of 3-aroylbenzo[b] thiophenes
11/30/1999	US5994367 Method for treating tumors using 2-aryl-naphthyridin-4-ones
11/30/1999	US5994361 Antitumor, anticancer agent
11/30/1999	US5994351 Antiarthritic agents; anticancer agents; antiulcer agents; enzyme inhibitors
11/30/1999	US5994350 Cardiovascular disorders; central nervous system disorders; gastrointestinal disorders; respiratory system disorders
11/30/1999	US5994344 Bronchitis therapy
11/30/1999	US5994342 3-(substituted methyl)-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives useful as antitumor agents
11/30/1999	US5994334 Androgen synthesis inhibitors
11/30/1999	US5994332 Antiinflammatory agents; immunomodulators; skin disorders
11/30/1999	US5994325 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
11/30/1999	US5994312 Peptidyl compounds
11/30/1999	US5994311 Using a oligopeptides, polypeptide
11/30/1999	US5994309 Anti-invasive and anti-angiogenic compositions and methods
11/30/1999	US5994298 Proteins for cancer cell specific induction of apoptosis and method for isolation thereof
11/30/1999	US5994293 Peptidyl compounds and their therapeutic use
11/30/1999	US5994119 Mammalian regulator of nonsense-mediated RNA decay
11/30/1999	US5994112 A polynucleotide which codes a protein; antiproliferative agents, anticarcinogenic agents, antiinflammatory agents
11/30/1999	US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999	US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999	US5993859 Pharmaceutical agents
11/30/1999	US5993829 Anti-cancer vaccine
11/30/1999	US5993828 Administering to the subject an effective dose of a composition comprising inactivated tumor cells having urinary tumor associated antigen on the cell surface and at least one tumor associated antigen
11/30/1999	US5993825 Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines

1 ... 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 ... 2211